Report: Prescription Drug Spending Tops Year-over-Year Price Growth for Selected Health Categories

Sep 15, 2015

"This latest health care price growth report indicates that spending on pricey prescription medications shows no sign of slowing down. When compared to other health care services, it is clear that high cost treatments continue to top the charts as a serious threat to the sustainability of our health care system and beyond." Read More

FDA Approves New Cholesterol-Lowering Treatments

Aug 28, 2015

"The approval of Repatha is another example of a breakthrough medication with a too high price tag. With several game-changing medications in the pipeline, we need to address the underlying issue of how these prices are set from the start before they hit the market.” Read More

PRESS STATEMENT: National Health Expenditure Projections Show Sharp Rise in Rx Spending

Jul 29, 2015

“These numbers paint a troubling picture for the future of the American economy. The dramatic rise in prescription drug spending proves that it is more important than ever to advance a solution to monopolistic drug pricing. We cannot afford to continue on this unsustainable path.” Read More

PRESS STATEMENT: FDA Approves Praluent, New Cholesterol-Lowering Treatment

Jul 24, 2015

“Breakthrough treatments such as Praluent hold tremendous medical promise for certain patients, but it’s price tag makes us question how long the health system can sustain these costs for patients managing chronic conditions over several years.” Read More

UAW Retiree Medical Benefits Trust Joins Campaign for Sustainable Rx Pricing

May 20, 2015

FOR IMMEDIATE RELEASE Contact: Kara Batt (571) 239-6547 [email protected] #### Read More

Press Release: New Trend Report Confirms Drug Prices On Unsustainable Path

May 13, 2015

May 13, 2015 New Drug Report Reveals Drug Costs Top $50,000/year for Over Half Read More